According to Dr. Richard Anderson of the University of Edinburgh, " A non-hormonal approach to male contraception using a drug which specifically targets a process in spermatogenesis has long been a very attractive option, as it leaves hormone production by the test is intact." He said it appeared that the drug effects could be fully reversible, although only a single dose was given in the study. He also added that Adjudin may be ineffective in men, as the biochemistry of the cell junctions it targets may be different, and the precise molecular basis of its mechanism of action is unknown. "However, perhaps the most important aspect of this study is the demonstration that using FSH targeting, drugs that are otherwise too toxic, can be delivered in safe yet effective doses."

Page 2 of 2 :: First | Last :: Prev | 1 2 | Next